Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status

被引:38
|
作者
Romera, Irene [1 ]
Fernandez-Perez, Sabela [1 ]
Luis Montejo, Angel [2 ]
Caballero, Fernando [3 ]
Caballero, Luis [4 ]
Angel Arbesu, Jose [5 ]
Delgado-Cohen, Helena [1 ]
Desaiah, Durisala [6 ]
Polavieja, Pepa [1 ]
Gilaberte, Inmaculada [1 ]
机构
[1] Lilly Spain, Dept Clin Res, Madrid, Spain
[2] Univ Hosp Salamanca, Sch Med, Salamanca, Spain
[3] Serv Madrileno Salad, Hlth Area 6, Primary Care Res Dept, Madrid, Spain
[4] Hosp Univ Puerta de Hierro, Madrid, Spain
[5] Ctr Salud Eria, Oviedo, Spain
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
Generalized anxiety disorder; Co-morbid major depressive disorder; Painful physical symptoms; Epidemiological study; Primary care; PHYSICAL SYMPTOMS; MENTAL-DISORDERS; COMORBIDITY; IMPAIRMENT; IMPACT; SCALE;
D O I
10.1016/j.jad.2010.05.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Painful physical symptoms (PPS) have received little attention in patients with generalized anxiety disorder (GAD). The objective of the present study was to assess the prevalence of PPS in patients with GAD vs patients with GAD and co-morbid major depressive disorder (MDD) and a control group (patients neither with GAD nor MDD). Methods: This is a cross-sectional, multi-center, epidemiological study, in primary care. Patients were screened for GAD (HADS-A), followed by a diagnosis confirmation (MINI). Patients were considered to have PPS when VAS overall pain score > 30. Functioning and health status was assessed (SDS, EUROQoL-5D). Relationships between the presence of PPS and functioning and health status was analyzed (ANCOVA models). Results were adjusted for confounding factors. Results: Of 7152 patients, 1546 (22%) screened positive for GAD, 981 (14%) had confirmed GAD diagnosis, of whom 559 (8%) had GAD with co-morbid MDD and 422 (6%) had GAD alone. Of the 5292 (74%) patients screened negative for GAD, 336 (5%) were confirmed as controls. PPS in patients with GAD were twice as prevalent as in the control group: 59.0% vs. 28.3%; p < 0.001. The presence of co-morbid MDD was associated with a significantly higher prevalence of PPS: 78.0% vs. 59.0%; p < 0.001. PPS were significantly associated with functioning and health status impairment (p < 0.001) both in GAD alone and in GAD and co-morbid MDD compared with controls. Limitations: Results do not prove causal relationships. Conclusions: Our results support the clinical relevance of PPS in patients suffering from GAD; therefore they need to be considered when evaluating the patient. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 50 条
  • [1] Insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Roth, Thomas
    Wilson, Phebe
    Schaefer, Kendyl
    Pfleeger, Kimberly
    Rubens, Robert
    Fava, Maurizio
    Pollack, Mark
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 85S
  • [2] Efficacy of venlafaxine and fluoxetine inpatients with major depressive disorder and co-morbid generalized anxiety disorder
    Silverstone, PH
    Salinas, EO
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S81 - S81
  • [3] Baseline insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder, generalized anxiety disorder, perimenopausal transition or rheumatoid arthritis
    Roth, T.
    Wilson, P.
    Schaefer, K.
    Rubens, R.
    Walsh, J.
    Krystal, A.
    [J]. SLEEP, 2007, 30 : A247 - A247
  • [4] Genome wide association scan of co-morbid anxiety in major depressive disorder (MDD)
    Schosser, A.
    Ng, M. Y.
    Butler, A. W.
    Uher, R.
    Cohen-Woods, S.
    Craddock, N.
    Owen, M.
    Aitchison, K. J.
    Breen, G.
    Craig, I.
    Farmer, A. E.
    Lewis, C. M.
    McGuffin, P.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 37 - 37
  • [5] Prevalence, Characteristics, and Attribution of Somatic Symptoms in Spanish Patients With Major Depressive Disorder Seeking Primary Health Care
    Caballero, Luis
    Aragones, Enric
    Garcia-Campayo, Javier
    Rodriguez-Artalejo, Fernando
    Ayuso-Mateos, Jose Luis
    Polavieja, Pepa
    Gomez-Utrero, Eduardo
    Romera, Irene
    Gilaberte, Immaculada
    [J]. PSYCHOSOMATICS, 2008, 49 (06) : 520 - 529
  • [6] DIAGNOSTIC OVERLAP OF GENERALIZED ANXIETY DISORDER AND MAJOR DEPRESSIVE DISORDER IN A PRIMARY CARE SAMPLE
    Zbozinek, Tomislav D.
    Rose, Raphael D.
    Wolitzky-Taylor, Kate B.
    Sherbourne, Cathy
    Sullivan, Greer
    Stein, Murray B.
    Roy-Byrne, Peter P.
    Craske, Michelle G.
    [J]. DEPRESSION AND ANXIETY, 2012, 29 (12) : 1065 - 1071
  • [7] Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Montgomery, S.
    Fava, M.
    Krystal, A.
    Wessel, T.
    Amato, D.
    Cooper, J.
    McCall, W. V.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [8] Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Montgomery, S.
    Wessel, T.
    Amato, D.
    Krystal, A.
    Hayduk, R.
    McCall, W. V.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S360 - S360
  • [9] Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
    Almeida, Susana S.
    Christensen, Michael Cronquist
    Simonsen, Kenneth
    Adair, Michael
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (03) : 279 - 288
  • [10] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Rubens, R.
    Amato, D.
    Kostal, A.
    Hayduk, R.
    McCall, W.
    [J]. SLEEP, 2007, 30 : A329 - A330